Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: PTFinder Dual-Channel NIR Autofluorescence Imaging System, Offline Machine-Learning Algorithm (PTFinder-AI Beta).
- Who it may be relevant to
- Registry conditions: Thyroid Neoplasms, Hyperparathyroidism, Parathyroid Gland. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Multicenter Prospective Paired Observational Study Evaluating the Performance of the PTFinder Dual-Channel Near-Infrared and White-Light Imaging System With AI-Assisted Analysis for Rapid Identification of Parathyroid Glands in Surgical Specimens
Overview
This study tests PTFinder, a dual-camera system that makes parathyroid glands glow on screen by capturing their natural near-infrared autofluorescence. After a thyroid or parathyroid operation, the removed tissue is scanned with PTFinder and then checked again under normal white light. We will measure how fast (seconds) and how accurately the device finds real glands, confirmed by frozen pathology or a rapid PTH strip. About 180 adult patients at three Chinese hospitals will join. The imaging adds only a few minutes and does not change any part of the surgery. We will also record blood calcium and PTH at 1 h, 24 h, and 7 d after surgery to see whether better gland recovery lowers low-calcium risk.Collected images will also be used to train and test a deep-learning model for fully automated parathyroid recognition; model performance metrics constitute secondary outcomes.
Detailed description
Prospective, paired, observational study at three endocrine-surgery centers. For each specimen:
PTFinder scan - stopwatch runs until the first gland is seen; all suspected glands are marked.
White-light exam - second investigator, blinded to device results, inspects the same specimen.
All marked tissue plus a random "negative" sample go to frozen section or rapid PTH strip; discrepancies are settled by permanent histology.
Outcomes
Primary - time to first gland; detection rate per specimen.
Secondary - sensitivity, specificity, PPV, NPV; post-operative PTH and calcium at 1 h, 24 h, 7 d; incidence of hypocalcaemia.
Sample size: 60 specimens per site (total = 180) gives 80 % power to detect a rise in detection rate from 70 % to 90 % (α = 0.05, McNemar).
Analysis: Paired tests for efficiency, mixed-effects models for accuracy and lab values; multiple imputation for missing data.
Safety \& Oversight: PTFinder emits low-intensity NIR light only on ex-vivo tissue; no patient exposure. Device is investigational, not under an FDA IDE. Ethics approval obtained from Fujian Medical University Union Hospital IRB (FJMU-IRB-2025-PTF); other sites use the same central IRB agreement. Data are stored in a secure eCRF.
Collected images will also be used to train and test a deep-learning model for fully automated parathyroid recognition; model performance metrics constitute secondary outcomes.
Interventions
- Device PTFinder Dual-Channel NIR Autofluorescence Imaging System
Ex vivo, non-contact imaging of resected thyroid/parathyroid specimens; captures near-infrared autofluorescence and overlays it on white-light video to highlight parathyroid glands (2-5 min per specimen). - Other Offline Machine-Learning Algorithm (PTFinder-AI Beta)
training/validation on de-identified NIR/RGB frames.
Primary outcome measures
- Detection Rate of Pathology-Confirmed Parathyroid Glands per Specimen (PTFinder) [Time frame: Intra-operative imaging session (0-5 minutes)]
Secondary outcome measures (6)
- Time to First Parathyroid Gland Identification (PTFinder) [Time frame: 1 day (Same imaging session)]
- Sensitivity of PTFinder [Time frame: 1 day (Same imaging session)]
- Specificity of PTFinder [Time frame: 1 day (Same imaging session)]
- Serum PTH Level [Time frame: 1 hour , 24 hours, 7 days post-op]
- Corrected Serum Calcium Level [Time frame: 1 hour , 24 hours, 7 days post-op]
- Incidence of Hypocalcaemia [Time frame: Up to 7 days post-op]
Eligibility criteria
Inclusion criteria
- Age ≥18 years.
- Scheduled for elective total thyroidectomy, hemithyroidectomy, or parathyroidectomy with removal of thyroid/parathyroid tissue.
- Able and willing to provide written informed consent for participation and specimen imaging.
Exclusion criteria
- History of neck irradiation or prior neck surgery that may distort parathyroid anatomy.
- Pregnancy or breastfeeding.
- Confirmed or suspected parathyroid carcinoma, or thyroid carcinoma requiring en-bloc parathyroid resection.
- Inability to understand the study procedures or to comply with follow-up.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Fujian Medical University Union Hospital — Fuzhou
Publications
- Wang B, Zhou CP, Ao W, Cai SJ, Ge ZW, Wang J, Huang WY, Yu JF, Wu SB, Yan SY, Zhang LY, Wang SS, Wang ZH, Hua S, Abdelhamid Ahmed AH, Randolph GW, Zhao WX. Exploring near-infrared autofluorescence properties in parathyroid tissue: an analysis of fresh and paraffin-embedded thyroidectomy specimens. J Biomed Opt. 2025 Jan;30(Suppl 1):S13702. doi: 10.1117/1.JBO.30.S1.S13702. Epub 2024 Jul 18. PMID 39034960
Identifiers
NCT: NCT07010380 · PTFinder 3 Dual